Vycor Medical, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-1.5M | $-1.7M | $-2.1M | $-4.0M | $-2.4M | $-2.9M | $-4.8M | $-2.0M |
| Depreciation & Amortization | $275.4K | $257.6K | $360.3K | $368.6K | $350.5K | $328.9K | $210.0K | $56.8K |
| Depreciation | $127.9K | $178.3K | $269.7K | $254.6K | $248.9K | $247.2K | $161.3K | $-35.3K |
| Amortization | $162.1K | $89.2K | $99.3K | $128.4K | $127.3K | $104.3K | $69.0K | $-21.5K |
| Stock-Based Compensation | $335.0K | $482.1K | $274.5K | $376.7K | $450.4K | $297.0K | $1.8M | $-342.9K |
| Net Cash from Operating Activities | $-527.4K | $-496.9K | $-1.2M | $-2.7M | $-758.4K | $-1.4M | $-3.2M | $-1.5M |
| Investing Activities | ||||||||
| Capital Expenditures | $183.3K | $57.5K | $210.0K | $130.8K | $128.1K | $28.2K | $62.0K | $21.5K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-183.3K | $-57.5K | $-294.3K | $-171.1K | $-358.0K | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $863.9K | $266.7K | $-85.3K | $4.7M | $1.1M | — | — | — |
| Net Change in Cash | $149.4K | $-290.6K | $-1.5M | $1.9M | $-28.5K | $-891.0K | $823.8K | $114.3K |
| Free Cash Flow | $-710.7K | $-554.4K | $-1.4M | $-2.8M | $-886.5K | $-1.4M | $-3.3M | $-1.5M |